We are live on
!
Find out more
CSCI
COSCIENS Biopharma Inc. Common Stock
CSCI
CSCI
Delisted
CSCI was delisted on the 3rd of September, 2025.
17 hedge funds and large institutions have $8.97M invested in COSCIENS Biopharma Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
826% more capital invested
Capital invested by funds: $969K → $8.97M (+$8M)
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
6% less funds holding
Funds holding: 18 → 17 (-1)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
Holders
17
Holders Change
-1
Holders Change %
-5.56%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
4
Reduced
2
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$4.88M |
| 2 |
TCM
Tenor Capital Management
New York
|
+$3.28M |
| 3 |
DM
Deerfield Management
New York
|
+$516K |
| 4 |
Renaissance Technologies
New York
|
+$310K |
| 5 |
Millennium Management
New York
|
+$86K |
Top Sellers
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$287K |
| 2 |
Two Sigma Investments
New York
|
-$61K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$54K |
| 4 |
Morgan Stanley
New York
|
-$45.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$25K |
